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Strength training is an eﬀective modality to improve muscular strength and functional performance in people with Parkinson’s
disease (PWP). One-repetition maximum (1-RM) is the gold standard assessment of strength; however, PWP suﬀer from day-
to-day variations in symptom severity and performance characteristics, potentially adversely aﬀecting the reliability of 1-RM
performance. Herein, we assessed the reliability of 1-RM in PWP. Forty-six participants completed two sessions of 1-RM testing of
knee extension, knee ﬂexion, chest press, and biceps curl at least 72 hours apart. Signiﬁcantly diﬀerences between testing sessions
wereidentiﬁedforkneeextension(P<0.001),kneeﬂexion(P =0.042),andbicepscurl(P =0.001);however,highreliability(ICC>
0.90) was also identiﬁed between sessions. Interestingly, almost third of subjects failed to perform better on the second testing
session. These ﬁndings suggest that 1-RM testing can be safely performed in PWP and that disease-related daily variability may
inﬂuence 1-RM performance.
1.Introduction
Parkinson’s disease (PD), a progressive neurological disease
which is believed to aﬀect over 1.5 million Americans, results
from the degeneration of the dopaminergic neurons in the
midbrain and the resulting reduced dopamine availability
to the basal ganglia [1, 2]. The cardinal features of PD
include rigidity, tremor, bradykinesia, and impaired postural
control, and these symptoms are often unpredictable and
their severity can ﬂuctuate daily, often termed “day-to-day
variability” [3–5]. Further, muscular weakness, identiﬁed
by Dr. Parkinson as an early symptom of the disease, is
also frequently reported by people with Parkinson’s (PWP)
[6, 7]. However, inconsistent ﬁndings in the literature have
obscured the elucidation of the underlying mechanism
of the apparent weakness, thus, raising the debate if
muscular weakness is intrinsic to the disease or a secondary
consequence [8, 9]. Muscular weakness, when present in
PWP, presents bilaterally and tends to increase as the velocity
of movement increases [9]. While the speciﬁc contributory
neurophysiological mechanisms remain uncertain, bradyki-
nesia, the inability to energize the appropriate muscles to
generate forces at a suﬃcient rate, is thought to be a major
contributing factor [8, 10]. Bradykinesia likely results from
basal ganglia pathophysiology leading to impairments in
both motor programming and execution [11]. Muscular
weakness and bradykinesia impair power production,
particularlyatlighterloads[8].Thesereductionsinmuscular
strength and power have been associated with both reduced
functional ambulation and impaired dynamic postural
stability in PWP [12–14]. As a result many patients with PD
receive physical therapy services to counteract these deﬁcits.
Recent reviews have suggested that strength training may
be an eﬀective modality to improve strength and functional
performance for PWP [15, 16]. Strength training has
frequently been combined with other rehabilitative proto-
cols including cueing strategies, aerobic or cardiovascular
training, balance training, stretching exercises, and creatine2 Parkinson’s Disease
supplementation in the development of global rehabilitation
programs [17–25] .T h e s ep r o g r a m sh a v el e dt oi n c r e a s e d
muscular strength [17–20], reduced bradykinesia [21], and
improved cognitive functioning [22, 23]. Further, these
improvementshavetransferredtooverallincreasedqualityof
life [21, 25] and improved functional performance including
gait [26], sit to stand [27, 28], sit to walk [29], and overall
functional mobility [18]. It is not surprising, therefore, that
strength training programs have become more integrated
into successful Parkinson rehabilitation programs.
An important ﬁrst step in initiating a rehabilitation
program is the assessment of baseline function by which
therapy-basedimprovementscanbejudged.Whenresistance
training is a component of the therapeutic protocol, assess-
ment of baseline strength is paramount. Though multiple
options exist, including more subjective manual muscle
testing,theacceptedgoldstandardofmaximalmuscletesting
is the use of the one-repetition maximum (1-RM) test [30].
The 1-RM is deﬁned as the maximal weight that can be
lifted once with correct lifting technique and is generally
considered to have good to excellent (ICC > 0.95) reliability
in healthy adults [31, 32]. However, therapists and rehabil-
itation specialists need to be aware of the determinants of
1-RM testing which include both previous weight training
experience and familiarization with the test [33–35]. Further
challenging the assessment of muscular performance are
disease-speciﬁc complications including the prevalent motor
ﬂuctuations, random changes in symptoms severity, and
noted “on/oﬀ” daily variability [36–38].
Previous rehabilitation studies in PWP have utilized
either one or two sessions of various strength testing proto-
colstoidentifytheindividual’scurrentstrength;however,the
reliability of these protocols, speciﬁcally maximal strength
assessment, has not been assessed in this population [17,
20, 24, 26]. Therefore, the purpose of this study was
to investigate the reliability of 1-RM testing in mild-to-
moderate PWP across two testing sessions. We hypothesized
that 1-RM testing would be generally reliable; however, the
disease related day-to-day variability associated with PD
would result in individuals diﬀerences during the testing.
2. Methods
2.1. Subjects. A total of 46 participants diagnosed with idio-
pathic PD by a movement disorder neurologist participated
in this study (Table 1). Inclusion criteria included a modiﬁed
Hoehn and Yahr stage 1–3, the ability to ambulate without
assistance, and stable response to anti-Parkinson medica-
tions. Exclusion criteria included cardiovascular, musculos-
ketal, vestibular disorders, or other neurological conditions
beyond PD or recent enrollment in an exercise training
program. All participants were tested while clinically “on”
approximately 1–1.5 hours following the ﬁrst medication
dose of the day and self-reported that their medicines were
working maximally at the time of testing. No participants
demonstrated any dyskinesia or freezing during the testing
sessions. All participants provided written informed consent
prior to participating in the study as approved by the
University’s Institutional Review Board.
Table 1: Participant demographics and anthropometric data.
Anthropometric data is presented as mean ± standard deviation.
Hoehn and Yahr classiﬁcation is presented as the actual number of
subjects and the percentage of the total (percentage does not add to
100% due to rounding).
Participant characteristics
Age (years) 62.6 ± 4.8
Height (m) 1.72 ± 0.11
Weight (kg) 86.8 ± 13.8
Disease duration (years) 10.9 ± 9.9
Hoehn & Yahr score 2.3 ± 0.6
Hoehn & Yahr 1 2 (4.3%)
Hoehn & Yahr 1.5 7 (15.2%)
Hoehn & Yahr 2 14 (30.4%)
Hoehn & Yahr 2.5 11 (23.9%)
Hoehn & Yahr 3 12 (26.1%)
Uniﬁed Parkinson Disease Rating Scale (UPDRS)∗
Total score 38.0 ± 6.1
Motor score 23.8 ± 4.6
ADL score 12.2 ± 2.2
∗UPDRS data was only available on 25 of the 46 subjects.
2.2. Experimental Procedures. Prior to performing the 1-
RM testing sessions, all participants underwent two famil-
iarization sessions, between 48–72 hours apart, to orientate
themselves with the exercise equipment. During these ses-
sions the appropriate positioning and lifting techniques were
instructed and each subject performed two sets of each
exercise at a low-to-moderate resistance level. The following
week, the 1-RM tests were performed using cable-loaded
resistance machines for knee extension (KE), knee ﬂexion
(KF) (New York Barbell, Elmira, NY.), chest press (CP), and
biceps curl (BC) (Nautilus Corp, Vancouver, WA.). Both the
1-RM testing protocol and the participants body alignment
for each tested closely adhered to the recommendations of
the National Strength and Conditioning Association [30].
For each exercise, subjects warmed up with a low resistance
and performed 10 repetitions. Thereafter, resistance was
increased in incremental loads until failure occurred despite
verbal encouragement to continue [17] .I no r d e rt ob e
classiﬁed as a successful attempt, the subject had to move the
weight through the complete range of motion in a controlled
manner without compensatory movements (e.g., shifting
body position). The1-RMwasdeterminedwithin5attempts
for all subjects.
In order to reduce the potential confounding eﬀects of
fatigue, no individual performed more than two 1-RM tests
inagivendayandatleast72hoursrestwasprovidedbetween
tests. Speciﬁcally, on a given test day the subject would
perform one upper body and one lower body assessment.
All 46 subjects performed the KE 1-RM tests, followed by 25
subjects performing the BC, 24 subjects performing the CP,
and 21 subjects performing the KF.
2.3. Statistical Analysis. The same investigator tested the
participants on both days. A paired sample T-test wasParkinson’s Disease 3






(kg) (95% CI) T-test results ICC (95% CI) SEM
Knee extension 63.7 ± 28.1 67.7 ± 29.7 4.0 (1.9–6.2) P<0.001 .96 (.93–.97) 5.7kg
Knee ﬂexion 27.0 ± 12.7 29.4 ± 13.0 2.4 (0.2–4.7) P = 0.042 .91 (.79–.96) 3.8kg
Biceps curl 43.9 ± 15.6 46.6 ± 17.6 2.7 (1.2–4.1) P = 0.001 .97 (.92–.98) 2.8kg
Chest press 57.8 ± 20.6 60.1 ± 20.8 2.3 (−0.2–4.7) P = 0.066 .95 (.90–.98) 4.3kg
ICC: Intraclass Correlation Coeﬃcient. SEM: Standard Error of Measurement which was calculated as: SEM: SDbaseline ∗
√
(1 −rtest–retest).
performed to compare diﬀerences between 1-RM during
session 1 and session 2 for each of the four exercises. The
mean diﬀerence and 95% conﬁdence intervals between the
two tests were calculated as session 2 minus session 1,
such that a positive number indicates an increase in 1-RM
duringsession2.Afrequencydistributionwasperformedfor
each exercise to identify which test session most commonly
represented the higher value. The intraclass correlation
coeﬃcient (ICC) was calculated for each exercise with a two-
way random eﬀects analysis of variance. Finally, the standard





All subjects completed all 1-RM tests without incident. The
paired analysis revealed statistically signiﬁcant diﬀerences in
1-RM performance between the two testing sessions for knee
extension, knee ﬂexion, and biceps curl, but not for chest
press (Table 2). The intraclass correlation coeﬃcient ranged
from 0.91 to 0.97 (Table 2).
Across the four exercises, a total of 116 tests were
performed; of these, 11.2% (13 of 116) had identical scores
between the two testing sessions. Further, 19.8% (23 of 116)
of the evaluations had higher 1-RM values, a mean of 4.6kg
across all 4 exercises, on the ﬁrst test. Finally, the range
of diﬀerences between the two testing sessions was 82% of
the combined means (54kg) with one participant increasing
their 1-RM by 41% (27kg) and another subject exhibiting a
41% (27kg) reduction in 1-RM, both occurred during knee
extension exercises, and over half of all participants (51%)
had changes of at least 5kg between test sessions.
4. Discussion
Eﬀective and reliable assessment of force production is an
integral component in the development of an appropriate
physical therapy program. Further, in longitudinal studies it
is essential to establish an accurate and reliable baseline per-
formance of strength to compare improvements over time.
The purpose of this study was to investigate reliability in 1-
RM performance amongst PWP. A primary ﬁnding of this
study was a signiﬁcant diﬀerence in 1-RM strength between
the two sessions for knee extension, knee ﬂexion, and
biceps curl exercises in individuals with mild-to-moderate
PD despite the subjects performing two orientation sessions
in the previous week. However, the tests demonstrated high
reliabilityandthebetweensessionsdiﬀerencesdidnotexceed
the standard error of measurement when collapsed across
participants. Interestingly, nearly third of subjects did not
increase their 1-RM on the second testing session as would
be expected in this inexperienced population. In some cases,
the improvements we observed (up to 41% improvement)
rival or exceed those reported in many longitudinal training
studies [17, 18, 20, 21]. This ﬁnding suggests that day-to-day
performance variability may play a substantial role in 1-RM
strength testing for individuals with mild-to-moderate PD.
Accurate and reliable baseline testing needs to be con-
ducted to correctly prescribe the treatment protocol and
elucidate improvements following exercise programs. The
results of this study suggest that more than one baseline 1-
RM test needs to be performed, although therapists should
not assume improved performance with second-day testing.
Indeed, over 30% of subjects failed to improve in 1-RM
performance on the second testing session and a between-
test range of 54kg was identiﬁed during the leg extension
exercise. This ﬁnding raises two unique concerns to the
development and reporting on the eﬀects of strengthening
programs for Parkinson’s rehabilitation. First, if the initial
1-RM value is low, the exercise prescription based on this
value may not be suﬃciently challenging to the individual,
thus, potentially limiting the eﬀectiveness of the therapy.
Secondly, variable performance raises the risk that the true
beneﬁt of the intervention may be masked by a single day
poor performance in a population known to experience day-
to-day performance variability [5, 40, 41]. The results of
this study are similar to recent ﬁnding of aerobic capacity
in PWP [42]. Katzel and colleagues demonstrated generally
high test-retest reliability, however a signiﬁcant between
test session, 0.56mL/mg/min, diﬀerence was noted in VO2
peak measurements [42]. Further, almost half of the PWP,
failed to improve on the second administration of the
maximal test (95% CI of −3.5–4.6mL/mg/min) [42]. Taken
together, these ﬁndings provide important considerations in
the development of rehabilitation programs for individuals
with mild-to-moderate PD.
The phenomenon of day-to-day variability in PWP has
been well established in the literature [5, 40, 41, 43]. The
symptoms of Parkinson’s, both physical and psychological,
are often unpredictable and ﬂuctuate from day to day result-
ing in substantial alterations in activities of daily living and
socialactivities[40,44].Thisisaseparatephenomenonfrom
motor ﬂuctuations, abrupt and unpredictable responses to4 Parkinson’s Disease
levodopaadministration[45].Further,bothhourlyanddaily
variations, potentially due to motor ﬂuctuations or day-to-
day variations, in gait rhythm (e.g., velocity, step length, and
cadence), have been identiﬁed in PWP [46]. The participants
in this study were all tested at a consistent time following
medication dosage, at their self-described best time of day,
and while clinically “on”; so only subtle motor ﬂuctuations
could have been a contributing factor to their performance.
The use of 1-RM testing has been examined in a wide
range of healthy, aging, and diseased populations [32, 35,
47–54]. In healthy young adults (age 18–30) with strength
training experience, the reliability of the 1-RM test is
generally considered to be very high (ICC > 0.95) [47,
55]. In healthy older adults, individuals with cardiovascular
disease, peripheral obstructive arterial disease, and chronic
obstructive pulmonary disease, 1-RM testing is a safe and
practical assessment and our results suggest 1-RM testing
is also safe amongst the PWP population with comparable
reliability [35, 52–54]. Interestingly, Schilling et al. [20]
recently found no diﬀerences in maximal relative strength
testing, reported as maximum strength divided by body
weight; however, these tests were separated by 8 weeks, as
opposed to 72 hours, and the time between tests may have
inﬂuenced the relation to our results. The results of the
current study suggest that PWP can safely and eﬀectively
perform 1-RM testing and, while important diﬀerences exist
between trials, the overall results are generally reliable.
Generallyspeaking, thereliability of1-RMmeasuresmay
vary depending on the individuals experience with weight
training and their familiarity with the speciﬁc exercise being
tested[32,33,47–49,55].Althoughthenumberofacceptable
familiarization sessions has ranged from one to nine, in
healthyinexperiencedmiddle-agedtoolderpopulations,one
to three familiarization sessions are generally considered to
be appropriate before assessing maximal strength [32, 34,
35]. Following familiarization with the equipment, most
studies on healthy older adults suggest that two to three
1-RM sessions are required as strength values will increase
on subsequent trials [33–35]. While the speciﬁc mechanism
underlyingtheseimprovementsin1-RMperformance,when
present, is not fully understood, it is generally attributed
to improved neural eﬃciency and activation patterns as
well as a learning eﬀect represented by improved posture
and exercise execution [33, 56]. Appropriate orientation and
familiarization to the testing paradigm is likely of particular
importance for PWP who are known to reduce overall
activity due to social stigmas, loss of conﬁdence in their
coordination, and fear of falling [26, 57].
The ﬁndings of this study are delimited to this speciﬁc
protocol, and future studies should address this potential
limitation by increasing the number of both familiarization
and 1-RM testing sessions to help elucidate the learning
eﬀects and the inﬂuence of day-to-day variability. Further,
additional demographic considerations (e.g., UPDRS scores)
and traditional performance variables (e.g., timed get-up
and go test) should be explored to identify potential rela-
tionships. However, exploratory analysis of our data found
no relationship between disease severity as measured by
Hoehn and Yahr staging, body weight or initial strength, and
the change in performance between testing sessions. While
day-to-day variability in PWP is unpredictable, exercise
intervention studies should consider a Parkinson’s speciﬁc
graded symptom checklist on the days of the pre- and
posttesting to attempt to control for the variability. Finally,
future studies should expand these ﬁndings by identifying
potential relationships between alterations in strength and
performance of activities of daily living.
The 1-RM test is generally considered to be the gold
standard for assessing maximal muscular strength in an indi-
vidual and the results of this study suggest that, when using
cable-loaded resistance machines, PWP can successfully
and safely perform these tests [30]. Thus, physical therapy
interventions can eﬀectively be established and monitored
with 1-RM testing in the PD population. Whereas healthy
older adults typically demonstrate subtle improvements in
1-RM performance with repeat administration over several
days, the results of this study suggest that individuals with
mild-to-moderate PD demonstrate inconsistencies in 1-RM
test performance.
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